A step toward ending the controversies in Hodgkin's disease
β Scribed by Kevin L. Schewe; Larry E. Kun; James D. Cox
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 185 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A retrospective analysis of 328 cases of Hodgkin's Disease (HD) subjected to a staging laparotomy at the Tata Memorial Hospital, Bombay, India, from 1974 to 1986 was undertaken to assess its relevance to our setup. Eighty percent of the patients were from clinical stages (CS) I and 11, 38% with lymp
## Abstract Levodopa is the most effective symptomatic agent in the treatment of Parkinson's disease (PD) and the βgold standardβ against which new agents must be compared. However, there remain two areas of controversy: (1) whether levodopa is toxic, and (2) whether levodopa directly causes motor